0001012975-17-000819.txt : 20171113 0001012975-17-000819.hdr.sgml : 20171110 20171113095618 ACCESSION NUMBER: 0001012975-17-000819 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171113 DATE AS OF CHANGE: 20171113 EFFECTIVENESS DATE: 20171113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Clarus Ventures, LLC CENTRAL INDEX KEY: 0001431431 IRS NUMBER: 202234539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16028 FILM NUMBER: 171193765 BUSINESS ADDRESS: STREET 1: 101 MAIN STREET STREET 2: SUITE 1210 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-949-2200 MAIL ADDRESS: STREET 1: 101 MAIN STREET STREET 2: SUITE 1210 CITY: CAMBRIDGE STATE: MA ZIP: 02142 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001431431 XXXXXXXX 09-30-2017 09-30-2017 Clarus Ventures, LLC
101 MAIN STREET SUITE 1210 CAMBRIDGE MA 02142
13F HOLDINGS REPORT 028-16028 N
Robert W. Liptak Managing Director 617-949-2200 /s/ Robert W. Liptak Cambridge MA 11-13-2017 0 5 122849 false
INFORMATION TABLE 2 ClarusQ317.xml VBI Vaccines Inc. COM 91822J103 10360 2691042 SH DFND 2691042 0 0 Sientra Inc. COM 82621J105 42054 2730765 SH DFND 2730765 0 0 Nanostring Technologies Inc. COM 63009R109 63985 3959440 SH DFND 3959440 0 0 Catabasis Pharmaceuticals Inc. COM 14875P107 5835 2752488 SH DFND 2752488 0 0 ESSA Pharma Inc. COM 29668H104 615 2121212 SH DFND 2121212 0 0